Our Pricing

Start Wegovy 0.5mg With Complete Price Transparency

Published on: June 03, 2026

If you're looking for the cheapest start Wegovy 0.5mg UK online, understanding the titration process and upfront costs is essential. At Cured Pharmacy, we provide genuine UK-licensed Wegovy pens from £79.00 with transparent pricing shown before your free clinical consultation. Our UK-registered prescribers assess your eligibility and guide you through the proper dose escalation schedule, ensuring safe and effective treatment from your very first injection.

Why Wegovy Always Starts at 0.25mg, Not 0.5mg

A common misconception is that Wegovy treatment begins at the 0.5mg dose. In reality, all patients licensed for Wegovy in the UK must start at 0.25mg for the first four weeks [1]. This lower starting dose allows your body to adjust to semaglutide gradually, significantly reducing the risk of gastrointestinal side effects such as nausea, vomiting, and diarrhoea.

The 0.5mg dose is actually the second step in the titration schedule, administered during weeks 5 through 8 [1]. This careful dose escalation is supported by data from the STEP clinical trial programme, which demonstrated that gradual titration improved treatment adherence and tolerability compared to starting at higher doses [2].

Attempting to bypass the 0.25mg starting dose is not recommended and would be considered off-label use in the UK. Your prescriber at Cured Pharmacy will ensure you follow the MHRA-approved titration schedule, which is designed to optimise both safety and weight loss outcomes.

The Complete Wegovy Titration Schedule Explained

Some patients may need to remain at the 0.5mg, 1mg, or 1.7mg dose for longer than four weeks if they experience persistent side effects. Your UK prescriber will monitor your progress through follow-up consultations and adjust the escalation timeline based on your individual tolerance and weight loss response. For the cheapest start Wegovy 0.5mg UK online, Cured Pharmacy provides ongoing clinical support throughout every phase.

Some patients may need to remain at the 0.5mg, 1mg, or 1.7mg dose for longer than four weeks if they experience persistent side effects. Your UK prescriber will monitor your progress through follow-up consultations and adjust the escalation timeline based on your individual tolerance and weight loss response.

Understanding Each Dose Escalation Phase

The full Wegovy titration protocol spans 16 to 20 weeks before reaching the maintenance dose of 2.4mg weekly [1]. After the initial 0.25mg dose for four weeks, you progress to 0.5mg for another four weeks. Subsequent monthly increases take you through 1mg, then 1.7mg, before finally reaching the therapeutic 2.4mg dose.

Each escalation step serves a specific physiological purpose: allowing GLP-1 receptors in your gastrointestinal tract and central nervous system to adapt to increasing semaglutide concentrations. Patients who rush this process or skip doses experience significantly higher rates of treatment discontinuation due to intolerable side effects [2].

Clinical Evidence: How Effective Is Wegovy for Weight Loss?

The STEP 1 trial, which enrolled 1,961 adults with obesity, demonstrated that patients on the full 2.4mg Wegovy dose achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% in the placebo group [2]. Importantly, 86.4% of participants in the Wegovy group lost at least 5% of their initial body weight, meeting the clinical threshold for meaningful weight loss.

These results were consistent across the broader STEP trial programme, which included patients with type 2 diabetes (STEP 2) and those maintaining weight loss after initial dietary intervention (STEP 4) [2][3]. The trials also showed improvements in cardiometabolic markers including HbA1c, blood pressure, and lipid profiles, independent of the degree of weight loss achieved.

It's crucial to understand that these outcomes reflect adherence to the full titration protocol and maintenance therapy, combined with lifestyle modification. Wegovy is not a standalone solution — clinical trials required participants to follow a reduced-calorie diet and increased physical activity programme [2]. Your prescriber will discuss realistic expectations based on your individual circumstances during your consultation.

Wegovy vs Other Weight Loss Treatments: What's the Difference?

Orlistat and Mysimba represent non-injectable alternatives with different mechanisms of action. Orlistat works by blocking fat absorption in the intestine, whilst Mysimba combines naltrexone and bupropion to reduce appetite through central nervous system pathways. Both are oral medications but generally produce more modest weight loss compared to GLP-1 receptor agonists [4].

Your choice of treatment depends on multiple factors: your BMI, medical history, previous weight loss attempts, tolerance for injections, and budget. At Cured Pharmacy, our UK prescribers assess all these variables during your free consultation to recommend the most appropriate option. All prescription weight loss medications require ongoing clinical monitoring and lifestyle modification for optimal results.

Comparing GLP-1 Receptor Agonists

Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics the action of glucagon-like peptide-1, a hormone that regulates appetite and food intake [1]. Saxenda, another injectable option, uses liraglutide — an earlier-generation GLP-1 agonist that requires daily injections rather than Wegovy's once-weekly administration.

However, eligibility extends beyond BMI thresholds. Your prescriber must also assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy [1]. Wegovy is not suitable during pregnancy or breastfeeding, and caution is required in patients with renal impairment. Choosing the cheapest start Wegovy 0.5mg UK online means ensuring all these checks are completed safely.

Who Can Start Wegovy 0.5mg Treatment in the UK?

Wegovy is licensed by the MHRA for adults with a BMI of 30 kg/m² or greater, or a BMI of 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1]. These criteria align with NICE guidance on pharmacological interventions for obesity management.

However, eligibility extends beyond BMI thresholds. Your prescriber must also assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy [1]. Wegovy is not suitable during pregnancy or breastfeeding, and caution is required in patients with renal impairment.

At Cured Pharmacy, our online clinical assessment takes under three minutes but covers all necessary medical history to ensure safe prescribing. Superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees our clinical governance framework, ensuring every prescription meets UK regulatory standards. If Wegovy is not appropriate for you, our prescribers will discuss alternative evidence-based options during your consultation.

Cheapest Start Wegovy 0.5mg UK Online: Transparent Pricing and Next Steps

Unlike many UK pharmacies that hide costs until after consultation, Cured Pharmacy displays transparent pricing upfront. The cheapest start Wegovy 0.5mg UK online begins from £79.00, with the exact cost determined by your prescribed dose and supply duration. This price includes your UK-licensed Wegovy pen, free clinical consultation with a UK prescriber, and discreet next-day delivery across the UK.

Once approved, your Wegovy pen is dispensed by our GPhC-registered pharmacy (registration number 9012511) and dispatched in 100% discreet packaging. You'll receive injection instructions, dose escalation guidance, and access to ongoing clinical support. Remember that all prescription medications require clinical assessment — we cannot supply Wegovy without a valid UK prescription, ensuring your safety and compliance with MHRA regulations.

What's Included in Your Wegovy Treatment at Cured Pharmacy

Unlike many UK pharmacies that hide costs until after consultation, Cured Pharmacy displays transparent pricing upfront. Wegovy treatment starts from £79.00, with the exact cost determined by your prescribed dose and supply duration. This price includes your UK-licensed Wegovy pen, free clinical consultation with a UK prescriber, and discreet next-day delivery across the UK.

There are no hidden consultation fees, subscription traps, or mandatory follow-up charges. You see the full cost before beginning your medical assessment, allowing you to make an informed decision about your treatment. We also offer £79.00 off your first weight loss treatment order, applied automatically at checkout.

Scientific References

1. Novo Nordisk. (2023). Wegovy 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and cannot be supplied without a valid prescription from a UK prescriber following clinical consultation.